Elbit Imaging Ltd is an Israel-based holding company. It operates in the fields of Commercial and Entertainment Centers, engaged in the initiation, construction and sale of shopping and entertainment centers and other mixed-use real property projects, predominantly in the retail sector; United States Real Property, investing in commercial real property in the United States; Hotels, engaged in the management and operation of hotels; Medical Industries, engaged in research and development, production and marketing of magnetic resonance imaging guided focused ultrasound treatment equipment and development of stem cell population expansion technologies and stem cell therapy products for transplantation and regenerative medicine; Residential Projects, engaged in the initiation, construction and sale of residential projects and other mixed-use real property projects, predominately residential, and Fashion Apparel, engaged in the Distribution and marketing of fashion apparel and accessories.

Elbit Imaging Ltd.

GE Healthcare provides medical technology, intelligent devices, and care solutions. They offer medical imaging, information technologies, medical diagnostics, patient monitoring systems, performance improvement, drug discovery, and biopharmaceutical manufacturing technologies. GE Healthcare's mission is to improve patient care and outcomes by providing innovative healthcare solutions. Their technologies are used in hospitals, clinics, research institutions, and pharmaceutical companies worldwide to diagnose and treat various medical conditions.

GE Healthcare

Boston MedTech Advisors provides comprehensive and practical business services leveraging its Principals and other Team members' unique perspective of the medical technology and healthcare industry and their understanding of the challenges companies and providers face in developing, commercializing or utilizing medical technology.    Boston MedTech Advisors understands the complex issues confronting manufacturers, marketers and providers in the highly competitive and continuously evolving healthcare industry, and they draw on their experience to help their clients and partners during each phase of the business cycle. Beginning with the early evaluation of the idea, through the development and subsequent commercialization of the product or service, Boston MedTech Advisors provides focused, comprehensive and cost effective solutions to their customers' challenges.

Boston MedTech Advisors

JGD Management Corp. doing business as York Capital Management is an employee owned hedge fund sponsor. The firm primarily provides its services to pooled investment vehicles. It also caters to high net worth individuals, pension and profit sharing plans, state or municipal government entities, charitable organizations, endowments, foundations, funds of funds, and institutions. The firm manages hedge funds for its clients. It invests in the public equity and fixed income markets across the globe. The firm primarily invests in companies undergoing mergers and acquisitions, distressed and restructuring companies; special situation equity including spin-offs and split-ups; bonds; warrants; and options. It employs a fundamental analysis with an event driven strategy and a bottom-up stock picking approach to make its investments. JGD Management was founded in 1991 and is based New York City with additional offices in Washington, DC; Singapore, Singapore; Moscow, Russia; London, United Kingdom; and Central, Hong Kong.

York Capital Management

Go Capital & EOC (GEOC) is an investment firm that invests in Israeli high-tech companies in areas of life Sciences, 3D printing, AI, IOT, and etc. GEOC has experienced Chinese and Israeli teams with business and international expertise which is complementary in territory, domain and resources. In the past 20 years, the core teams of both China and Israel have been focusing on advancing those areas of interest. The Fund identified the growing potential in China – Israel relations in the political and economic arenas with complementary objectives and growing business opportunities. GEOC's vision is to be the innovation platform and growth engine for deep integration of advanced Israeli technology and Chinese manufacturing industry and huge market.

GEOC

Koch Disruptive Technologies (KDT), founded in November 2017 with a transformational spirit, originates and invests in promising entrepreneurs and technologies across industries to improve Koch Industries' existing businesses and create new opportunities. Based in Wichita, Kansas, Koch Industries is one of the largest private companies in America with estimated annual revenues as high as $100 billion, according to Forbes. It owns a diverse group of companies involved in refining, chemicals, and biofuels; forest and consumer products; fertilizers; polymers and fibers; process and pollution control equipment and technologies; electronics; information systems; commodity trading; minerals; energy; glass; ranching; and investments. Since 2003, Koch Companies have invested more than $80 billion in acquisitions and other capital expenditures. With a presence in about 60 countries, Koch Companies employ more than 120,000 people worldwide, with about 70,000 of those in the United States. From January 2009 to the present, Koch Companies have earned more than 1,200 awards for safety, environmental excellence, community stewardship, innovation, and customer service.

Koch Disruptive Technologies

Focus Holdings

MedTech Advisors specializes in providing investment and consulting services exclusively to emerging medical technology companies. With a focus on aiding these companies in achieving their business objectives, MedTech Advisors leverages its expertise in the medical technology field to offer strategic guidance, operational support, and investment opportunities. The team, led by professionals with significant experience in the medical technology sector, works closely with clients to navigate the complexities of the industry, ensuring ethical and result-oriented outcomes. Services are tailored to meet the unique needs of each client, encompassing a wide range of support from strategic planning to market entry strategies.

MedTech Advisors

Ruby Ventures is a diversified investment company owned and managed by the Rubinstein family of Canada and Israel. The family is a founding partner in the well known and highly regarded Toronto-based real estate firm of H&R Developments. While boasting a variety of investments, Ruby Ventures mainly focuses on innovative real estate and groundbreaking technology.  It is primarily within these industries that Ruby Ventures leverages its extensive experience and a network of contacts to identify and participate in exceptional investment opportunities.

Ruby Ventures

Fidelity is a privately owned investment management firm that serves a wide range of clients. It offers services including IRAs, rollovers, annuities, discount brokerage, retirement planning, estate planning, wealth management, securities execution and clearance, and life insurance. They serve individual investors, businesses, financial advisors, and institutions. The firm manages equity, fixed-income, and balanced mutual funds and invests in public equity and fixed-income markets. It also conducts in-house research to inform its investment decisions.

Fidelity

Ally Bridge Group is a healthcare-focused investment group committed to venture and growth capital, buyout, and hedge fund investing. Ally Bridge Group focuses on both private and public equity investments, with a particular emphasis on pioneering life sciences companies and technologies. The firm is dedicated to bridging the gap between groundbreaking healthcare innovations and global markets. By leveraging its expertise and extensive network, Ally Bridge Group supports the growth and development of its portfolio companies. Its investment strategy is centered on transformative technologies and solutions that address major unmet medical needs.

Ally Bridge Group

Nexus NeuroTech operates as a venture capital firm.

Nexus NeuroTech

Perceptive Advisors is a privately owned hedge fund sponsor. The firm invests in the public equity markets across the globe. It employs a long/short equity strategy as a hedging technique while investing. The firm typically invests in the biotechnology and life sciences sectors to make its investments. Perceptive Advisors is based in New York, New York.

Perceptive Advisors

Baillie Gifford is an independently owned investment management firm. It is owned and run by 39 of its senior executives, who operate as a partnership, a structure that has endured for over a century and provides stability for clients and motivation for employees. It enables them to manage the business for the future as well as the present, with an emphasis on genuine long-term thinking rather than lurching haplessly between short-term targets.

Baillie Gifford

Fayez Sarofim and Co. manages investment portfolios for a wide range of clients â€” pension plans, foundations, endowments, and individuals. For over four decades since their founding in 1958, they have focused exclusively on investment management. The firm is an independent entity owned and managed by its founder, Fayez Sarofim, and a team of 21 investment professionals. As of September 30, 2008, the firm had $25 billion in assets under management.

Fayez Sarofim & Co.

Catalio Capital Management is a venture capital firm that invests in breakthrough biomedical technology companies. It was created by George Petrocheilos and Dr. Jacob Vogelstein in 2020.

Catalio Capital Management

Gilmartin Capital is focused on private investments in the medical device, life science tools, diagnostic and digital health sectors.

Gilmartin Capital LLC

InSightec

InSightec is the pioneer and global leader in MR guided focused ultrasound technology for image guided acoustic surgery.  ExAblate® 2000 system was the first system to use the MR guided focused ultrasound technology. The ExAblate system received CE mark in 2002 and the Food and Drug Administration (FDA) approval in 2004 for the treatment of symptomatic uterine fibroids. ExAblate received the European CE Mark for pain palliation of bone metastases in June 2007 and for adenomyosis in June 2010. This device has won numerous innovation awards and has been used to treat thousands of patients around the world.

<div>  <p>    Insightec developed the Exablate Prime platform, which uses MRI-guided focused ultrasound for incisionless neurosurgery to treat essential tremor and Parkinson's disease. The company received FDA approval for treating advanced Parkinson's disease in 2021. In June 2024, Insightec raised USD 150 million to expand its incisionless neurosurgery treatments and invest in new indications. With over 160 systems installed worldwide, Insightec's technology has been used in nearly 20,000 commercial applications.  </p>  <p>  </p></div>

Insightec Raises $150M in Equity Financing

Pushing the envelope in MedTech with emerging technologies

Next-gen Medical Devices

Companies that develop diagnostic devices used in a hospital setting to identify a disease, condition, or injury, such as imaging systems and endoscopes

Companies that develop implantable medical devices designed to be surgically placed inside the human body, either temporarily or permanently, including devices such as pacemakers, artificial joints, stents, and cochlear implants

Companies that develop non-surgical devices that are used in a procedure or intervention to cure or relieve a patient from an illness or disease such as laser treatments, dental equipment, and wound care management

Companies that develop monitoring devices that are used in a hospital setting to measure patient vital signs and ensure patient well-being post-treatment, such as cardiac and respiratory monitoring systems

Providers of software that enhances the functionality of medical device hardware (diagnosis, treatment, and monitoring)

Companies that develop surgical devices involving invasive interventions (cutting into a patient's body tissues) to treat, cure, or relieve a patient of an illness or disease

Companies that develop devices to administer pharmaceutical substances into a patient's body, ensuring controlled release or targeted delivery, specifically for use in clinical settings to treat or manage medical conditions effectively

Providers of software that helps manage risks, ensure quality, and streamline audit processes during medical device development

INCUMBENTS_PRESENT

<div>
 
 <p>Insightec has secured FDA approval and the CE mark for its Exablate Prime system, compatible with certain Philips MR systems.</p>
 <p>Exablate Prime utilizes MRI-guided sound waves for treating patients with medication-resilient essential tremors and Parkinson's disease. This can be done in a single outpatient procedure. The system has received FDA approval to treat both sides of the body, often leading to immediate patient improvement with minimal or no complications.</p>
 <p>As of early 2024, Insightec has successfully installed over 160 systems globally, with almost 20,000 commercial applications to date.</p>
 
</div>

InSightec

Featured Industries

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless